Key facts
- MediVR’s last known valuation is $19.5M (Feb 2025).
- It has raised $9.4M; the latest was Later Stage VC ($1.8M) in Feb 2025.
- Notable investors include Mitsubishi UFJ Capital, J-Startup, DBJ Capital, Nanto Capital Partners, Kyoshin Social Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for MediVR
- ·The full record, as it builds
Funding rounds
No funding rounds for MediVR are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MediVR
Developer of a virtual reality-based medical device designed to improve visualization. The company's platform offers different body movement exercises and the device uses virtual reality to recover balance and mobility by playing games and completing various activities using a base station, virtual reality headset, and a pair of handheld controllers, enabling clinicians and families to accelerate rehabilitation in patients with stroke.
- Sector
- Healthcare
- HQ
- Osaka, Japan
- Founded
- 2016
- Employees
- 20
- Website
- medivr.jp/
- Ownership
- Privately Held (backing)
MediVR doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediVR shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediVR in its N-PORT filings yet. We sweep new filings monthly.